Back to mobile site

JMP Securities Reiterates Market Outperform Rating on Marinus Pharmaceuticals (MRNS)

August 13, 2024 4:09 PM EDT Send to a Friend
JMP Securities analyst Jason N. Butler reiterated a Market Outperform rating and $10.00 price target on Marinus Pharmaceuticals (NASDAQ: MRNS).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login